BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28001000)

  • 1. Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation.
    Houben-Wilke S; Spruit MA; Uszko-Lencer NHMK; Otkinska G; Vanfleteren LEGW; Jones PW; Wouters EFM; Franssen FME
    Respirology; 2017 Jul; 22(5):928-934. PubMed ID: 28001000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study.
    Smid DE; Wilke S; Jones PW; Muris JW; Wouters EF; Franssen FM; Spruit MA
    BMJ Open; 2015 Jul; 5(7):e007536. PubMed ID: 26198426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.
    Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Kollen BJ; Sanderman R; Schultz K; Kocks JWH; Van der Molen T
    Health Qual Life Outcomes; 2018 Jun; 16(1):130. PubMed ID: 29940980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness and MCID Estimates for CAT, CCQ, and HADS in Patients With COPD Undergoing Pulmonary Rehabilitation: A Prospective Analysis.
    Smid DE; Franssen FM; Houben-Wilke S; Vanfleteren LE; Janssen DJ; Wouters EF; Spruit MA
    J Am Med Dir Assoc; 2017 Jan; 18(1):53-58. PubMed ID: 27624705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference.
    Alma H; de Jong C; Jelusic D; Wittmann M; Schuler M; Flokstra-de Blok B; Kocks J; Schultz K; van der Molen T
    NPJ Prim Care Respir Med; 2016 Sep; 26():16041. PubMed ID: 27597571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD.
    Braeken DCW; Spruit MA; Houben-Wilke S; Smid DE; Rohde GGU; Wouters EFM; Franssen FME
    Respirology; 2017 Jul; 22(5):942-949. PubMed ID: 28139873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPD.
    Cuttica MJ; Bhatt SP; Rosenberg SR; Beussink L; Shah SJ; Smith LJ; Dransfield MT; Kalhan R
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1439-1446. PubMed ID: 28553096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airflow obstruction and left ventricular filling pressure in suspected chronic obstructive pulmonary disease.
    Yu YH; Chen MZ; Wen LL; Chu CC; Chiang CT; Chen CH; Lin YJ
    Respir Physiol Neurobiol; 2014 Feb; 192():85-9. PubMed ID: 24361463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and clinical characteristics in patients with chronic obstructive pulmonary disease.
    Cleutjens FAHM; Spruit MA; Ponds RWHM; Vanfleteren LEGW; Franssen FME; Gijsen C; Dijkstra JB; Wouters EFM; Janssen DJA
    Chron Respir Dis; 2018 May; 15(2):91-102. PubMed ID: 28553720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation.
    Ringbaek T; Martinez G; Lange P
    COPD; 2012 Feb; 9(1):12-5. PubMed ID: 22292593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Cognitive Impairment on Efficacy of Pulmonary Rehabilitation in Patients With COPD.
    Cleutjens FAHM; Spruit MA; Ponds RWHM; Vanfleteren LEGW; Franssen FME; Dijkstra JB; Gijsen C; Wouters EFM; Janssen DJA
    J Am Med Dir Assoc; 2017 May; 18(5):420-426. PubMed ID: 28108209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular volume and wall stress are linked to lung function impairment in COPD.
    Alter P; Jörres RA; Watz H; Welte T; Gläser S; Schulz H; Bals R; Karch A; Wouters EFM; Vestbo J; Young D; Vogelmeier CF
    Int J Cardiol; 2018 Jun; 261():172-178. PubMed ID: 29657040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the impact of impaired left ventricular ejection fraction in COPD after adjusting for confounders?
    Mesquita R; Franssen FM; Houben-Wilke S; Uszko-Lencer NH; Vanfleteren LE; Goërtz YM; Pitta F; Wouters EF; Spruit MA
    Int J Cardiol; 2016 Dec; 225():365-370. PubMed ID: 27760413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thresholds for clinically important deterioration versus improvement in COPD health status: results from a randomised controlled trial in pulmonary rehabilitation and an observational study during routine clinical practice.
    Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Sanderman R; Schultz K; Kocks J; van der Molen T
    BMJ Open; 2019 Jun; 9(6):e025776. PubMed ID: 31256021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and Prognostic Associations of Echocardiographic Pulmonary Hypertension With Normal Left Ventricular Systolic Function in Patients ≥90 Years of Age.
    Shimada S; Uno G; Omori T; Rader F; Siegel RJ; Shiota T
    Am J Cardiol; 2020 Aug; 129():95-101. PubMed ID: 32624190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oscillatory Positive Expiratory Pressure in Chronic Obstructive Pulmonary Disease.
    Svenningsen S; Paulin GA; Sheikh K; Guo F; Hasany A; Kirby M; Rezai RE; McCormack DG; Parraga G
    COPD; 2016; 13(1):66-74. PubMed ID: 26430763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study.
    Alma H; de Jong C; Jelusic D; Wittmann M; Schuler M; Kollen B; Sanderman R; Kocks J; Schultz K; van der Molen T
    J Clin Epidemiol; 2019 Dec; 116():49-61. PubMed ID: 31362055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Clinical COPD Questionnaire: A systematic review.
    Zhou Z; Zhou A; Zhao Y; Chen P
    Respirology; 2017 Feb; 22(2):251-262. PubMed ID: 28102972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients.
    Jo YS; Park S; Kim DK; Yoo CG; Lee CH
    BMC Pulm Med; 2018 Feb; 18(1):38. PubMed ID: 29482616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.